Brandywine Realty Trust

Second-quarter net loss was $31 million, or $0.18 per share. FFO totaled $23.6 million, or $0.13 per diluted share, ahead of prior guidance and $0.01 below consensus. Same-store results were up 0.5% on a GAAP basis and 1.9% on a cash basis. The wholly owned portfolio ended the quarter 90.6% leased and 89.1% occupied, with 353,000 square feet of leasing signed and 88,000 square feet of positive net absorption. Full-year guidance was updated as follows: disposition sales were raised to $305 million, tenant retention midpoint was lifted to 51% to 53%, full-year FFO midpoint was maintained at $0.55, and third-quarter core FFO guidance was set at $0.13 to $0.15 per share. For Q3, property-level operating income is expected to be about $69.5 million, G&A about $7.5 million, interest expense about $40 million, termination fee and other income $2.8 million, net third-party fees about $1.5 million, and interest income about $500,000.

Jerry Sweeney emphasized that the quarter came in at or ahead of plan operationally, with leasing momentum, stronger retention, and better-than-expected speculative revenue. He was constructive on portfolio quality and market conditions, especially in Philadelphia, where the company continues to gain share and where office-to-residential conversion activity could further improve fundamentals. His tone was upbeat but disciplined, repeatedly tying strategy to balance-sheet repair, deleveraging, and selective capital recycling rather than broad growth at any cost.

Tom Wirth said the quarter’s FFO performance reflected mostly in-line property NOI, interest expense, and other items, with JV FFO $300,000 above forecast, G&A $200,000 below forecast, and third-party fees $1.3 million above forecast. He highlighted solid liquidity with $35 million of cash and no revolver balance, noted that the company repaid the $178 million construction loan with a $90 million secured loan on VERA’s residential piece, and said the new secured financing carried an all-in fixed rate of 5.8%. He also said second-half capital activity totals about $250 million, including $290 million of asset sales as a source, and that year-end net debt to EBITDA is expected to remain elevated at 8.4x to 8.8x until more sales and recapitalizations close.

Analysts pressed on the 3.15 million square foot Uptown/IBM redevelopment, asking about tenant mix and whether life sciences are improving; management said there is a multi-floor tenant in advanced lease negotiations and that life sciences are seeing a modest rebound, helped by Pennsylvania’s $125 million Innovate 2.0 program. Questions also focused on the asset-sale strategy and the split between debt reduction and buybacks; management said the main goal is investment-grade metrics, with only 5% to 10% of proceeds likely to go to share repurchases while the bulk goes to debt reduction and bond buybacks. On Austin, management said 405 Colorado drew strong bids and sold at a cap rate around 8% or slightly above, and that Solaris and 1 Uptown are likely to be recapitalized or sold in the second half of the year.